Back to Traditions – The Allopathic Spiral Downwards!
The under-performance of certain pharmaceutical products of Allopathic origin has been reported in modern times. A number of synthetic drugs have adverse and unacceptable side effects. Problems with drug-resistant microorganisms, side effects of modern drugs, and emerging diseases where no medicines are available, have also stimulated a renewed interest in plants as a significant source of new medicines. There have been impressive successes with botanical medicines from Ayurvedic and Chinese Traditional medicine Archives. Many vital treatment molecules have come out of Ayurvedic experiential base. These include: Rauwolfia alkaloids for Hypertension, Psoralens for Vitiligo, etc. A whole range of chronic and difficult-to-treat diseases such as Cancers, Cardiovascular disease, Diabetes, Rheumatism, and AIDS, now require new and effective drugs.
Adding on to the above stated issues of bodily affects most developing countries have relied and will continue to rely on traditional natural medicines due to the deterrence of high costs of modern allopathic medicines. Current estimates indicate that about 80% of people in developing countries still rely on traditional medicine based largely on various species of plants and animals– for their primary healthcare. Hence, it is no surprise to see people shift to Natural medicine.
PS: This Post is an adaptation of a section from the Research Paper titled ‘Ayurveda and natural products drug discovery’ by Bhushan Patwardhan, Ashok D. B. Vaidya and Mukund Chorghade. This was published in the Current Science magazine, Vol. 86, No. 6 on the 25th of March 2004. We gratefully thank the authors for this perspective and this post is not suggestive of our ideology.